Preparation, characterization and in vitro cytotoxicity of paclitaxel-loaded sterically stabilized solid lipid nanoparticles.
about
Toxicity of nanomaterialsPhysicochemical properties of nanomaterials: implication in associated toxic manifestationsMultiscale observation of biological interactions of nanocarriers: from nano to macro.Improved brain delivery of vincristine using dextran sulfate complex solid lipid nanoparticles: optimization and in vivo evaluation.Novel pH-sensitive polyacetal-based block copolymers for controlled drug delivery.Intracellular uptake of etoposide-loaded solid lipid nanoparticles induces an enhancing inhibitory effect on gastric cancer through mitochondria-mediated apoptosis pathway.Human serum albumin nanoparticles as an efficient noscapine drug delivery system for potential use in breast cancer: preparation and in vitro analysisSustained release of VEGF from PLGA nanoparticles embedded thermo-sensitive hydrogel in full-thickness porcine bladder acellular matrix.Ceramide and N,N,N-Trimethylphytosphingosine-Iodide (TMP-I)-Based Lipid Nanoparticles for Cancer Therapy.Nanostructured lipid carriers (NLC) for parenteral delivery of an anticancer drugEnhanced bioavailability and efficiency of curcumin for the treatment of asthma by its formulation in solid lipid nanoparticlesA critical review of lipid-based nanoparticles for taxane delivery.pH-sensitive strontium carbonate nanoparticles as new anticancer vehicles for controlled etoposide release.2'-Behenoyl-paclitaxel conjugate containing lipid nanoparticles for the treatment of metastatic breast cancerPaclitaxel Nano-Delivery Systems: A Comprehensive Review.Solid lipid nanoparticle formulations of docetaxel prepared with high melting point triglycerides: in vitro and in vivo evaluation.Advances in novel drug delivery strategies for breast cancer therapy.Lipid nanoparticles for the delivery of poorly water-soluble drugs.Lipid nanoparticles for cancer therapy: state of the art and future prospects.Paclitaxel drug delivery systems.Physicochemical characterization techniques for solid lipid nanoparticles: principles and limitations.Lipid-based nanocarriers for breast cancer treatment - comprehensive review.Physicochemical characterization of chitosan-hyaluronan-coated solid lipid nanoparticles for the targeted delivery of paclitaxel: a proof-of-concept study in breast cancer cells.Development and optimization of transferrin-conjugated nanostructured lipid carriers for brain delivery of paclitaxel using Box-Behnken design.New Oral Formulation and in Vitro Evaluation of Docetaxel-Loaded Nanomicelles.Cellular uptake and antitumour activity of paclitaxel incorporated into trilaurin-based solid lipid nanoparticles in ovarian cancer.One-step bulk preparation of calcium carbonate nanotubes and its application in anticancer drug delivery.Thermoreversible Pluronic F127-based hydrogel containing liposomes for the controlled delivery of paclitaxel: in vitro drug release, cell cytotoxicity, and uptake studies.In vitro cytotoxic activity of cationic paclitaxel nanoparticles on MDR-3T3 cells.Liposome composition is important for retention of liposomal rhodamine in P-glycoprotein-overexpressing cancer cells.Paclitaxel-loaded glyceryl palmitostearate nanoparticles: in vitro release and cytotoxic activity.Development of new lipid-based paclitaxel nanoparticles using sequential simplex optimization.Optimization of solid lipid nanoparticles prepared by a single emulsification-solvent evaporation method.Evaluation of Stability and In Vitro Security of Nanoemulsions Containing Eucalyptus globulus Oil.Development of lipid-based nanoparticles for enhancing the oral bioavailability of paclitaxel.Tripalmitin nanoparticle formulations significantly enhance paclitaxel antitumor activity against breast and lung cancer cells in vitro.Biocompatibility of a Self-Assembled Crosslinkable Hyaluronic Acid Nanogel.Nanostructured lipid carriers as a delivery system of biochanin A.Solid lipid nanoparticles reduce systemic toxicity of docetaxel: performance and mechanism in animal.Targeted brain delivery of itraconazole via RVG29 anchored nanoparticles.
P2860
Q28383168-A6396EFD-F0A0-4C45-9F6A-5F84377CFD07Q28392831-45BF3C88-9F44-4CB0-B3AC-B64821FC9670Q30474384-BF39E086-3123-46C2-890E-1C173F7C5738Q30657827-64E42564-0096-44E6-9ADC-6C9E98A1ABE6Q33676634-FCF73CBB-7DB8-479D-AB1D-3B4B287BF6F8Q34110108-19EA995D-8AF5-4CD1-B9AB-49C84F528633Q34170177-43977B2F-6E9E-4E2E-BF0E-592560DC3D7FQ35536972-D3434B09-6AEA-4FB5-BDF6-A7EF016CA463Q35764089-6FEE6C69-9059-4528-B6DD-F1007E1267ECQ35821866-90DBEB8A-E2BC-48E6-B22F-9FBAF540AB90Q36148565-214BBF5F-2F26-4A86-891B-B0D3587C33F5Q36360764-BCCD0592-C842-4463-A960-F17A61BA5FFFQ36422796-5E9DF85F-03CC-4975-83D9-88D12E4ACF43Q36468079-E5D96340-4A97-4840-A804-22B7315BCF76Q37250009-2827C6FF-577B-4C08-8D24-ED8D462BE10AQ37714256-96606FDA-13BC-4A30-940F-FF41FB9648C8Q37777142-AC9440B2-8B80-4C6C-8376-700BBD39FE25Q37805594-BF5724A6-98A4-402F-8F84-A5FCDB708431Q38040884-34D19110-000A-4AC0-B6A5-74C1D016ABCDQ38071668-7EDC4849-2678-482D-836C-427CD04FEE6AQ38207151-11D4FFB9-E0F1-4550-A644-C018B1A84113Q38597794-B4330120-ADB0-416B-AC47-A9ABA7627D7CQ38717148-4DA4AFB5-798F-4398-9808-C386282C5EA9Q38743036-5E8026F6-D417-4A8E-B1FF-FA07616715EAQ38744407-CFE6871C-B898-41DB-B599-F0D4091B365CQ39164588-26531817-1F96-45C4-8C1F-2FA5199FE250Q39393200-1F3F106F-2D03-425A-A575-E553891FBCEEQ39557339-708712D3-8D80-4A7F-88F6-3CE66168C304Q39754432-E2A8CE84-50AA-441E-BE6D-3E00D9CCD384Q39836322-2E9E351D-A5DB-4BF9-9531-8DE9C5AB2B95Q39877747-07B4B364-B5D5-413E-A10B-92CFDD50BF82Q39900986-24A5E9B3-0A8C-4E08-AE74-D626F4A39EEBQ40115098-D9E78D69-A642-4763-8684-529BFC2C5E6EQ41038538-3CC538BB-D9C2-419B-AD2E-8700E7CFFDDFQ41988569-00AE942D-336C-44C5-9A83-2FDE9B723866Q42658800-AF2B06B1-E753-44ED-A088-144CDC10915FQ42808694-D25A9D6E-1F91-40EA-906B-53BD710964BAQ45415768-3BBF95DC-8600-4D3A-8F16-038D1B0A2579Q46729488-D7BB25E0-40D0-47F5-A9EF-1DA8FC259D54Q48169419-8467E0F2-F61A-4FED-8541-A11CBAF5850B
P2860
Preparation, characterization and in vitro cytotoxicity of paclitaxel-loaded sterically stabilized solid lipid nanoparticles.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Preparation, characterization ...... zed solid lipid nanoparticles.
@en
type
label
Preparation, characterization ...... zed solid lipid nanoparticles.
@en
prefLabel
Preparation, characterization ...... zed solid lipid nanoparticles.
@en
P2093
P1433
P1476
Preparation, characterization ...... zed solid lipid nanoparticles.
@en
P2093
Chong-Kook Kim
Mi-Kyung Lee
Soo-Jeong Lim
P304
P356
10.1016/J.BIOMATERIALS.2007.01.014
P577
2007-01-10T00:00:00Z